A series of 4 modules that includes your Reflective Learning Guide downloads with opportunity for CPD certification.
Off
Helping you improve the lives of people living with immunological conditions.
UCB’s ambition is to improve the lives of people living with severe diseases.
Alongside our proven therapies we have invested in this resource to support your drive for optimal patient outcomes, accredited education, practice insights and clear concise treatment data.
We have teamed up with a variety of specialist healthcare professionals and experts to bring you the most relevant data and advice for your field.
Off
What's on UCB connect
paragraph-section-webinars
CPD certified content
Head to the Rheumatology and Dermatology pages for:
Live webinars | Podcasts | Expert videos | Reports | Learning modules | Useful materials
Product information
Head to the treatments page for:
Key study summaries | Efficacy overviews | Safety profile information | Dosing and administration guides | Molecular structure information | Order patient materials
Connect with us
Contact us
Arrange a meeting with a UCB representative or UCB Medical Information
Off
What's new
Date of preparation: June 2022
| IE-P-CZ-axSpA-2200048
Evolution in Rheumatology for Nurses Highlights 2022
Off
Orbit 360 enabled
On
Date of preparation: March 2023
| GB-P-CZ-axSpA-2300013
Pharmacist Evolution in Rheumatology 2023
Friday 19th May 2023
This meeting is aimed at Specialist Rheumatology Pharmacists and is initiated and funded by UCB Pharma Ltd.
For UK Healthcare Professionals only.
The purpose is to address the unmet educational needs of Rheumatology Pharmacists to enhance clinical change in a simplified way.
Meeting Co-Chairs:
Ms Kalveer Flora and Karl Gaffney
Pharmacist Evolution in Rheumatology 2023
Off
Orbit 360 enabled
Off
Off
Why connect with UCB connect?
Because we're in this together...
Report adverse events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk and hpra.ie/homepage/about-us/report-an-issue.
Adverse events should also be reported to UCB Pharma Ltd Email: UCBCares.UK@ucb.com and UCBCares.IE@ucb.com.
Feature requests
Help us to grow our resource the way you want it to grow.
Date of preparation: November 2022
IE-P-CZ-AS-2100007